Michael E. Brune

1.5k total citations
41 papers, 746 citations indexed

About

Michael E. Brune is a scholar working on Urology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael E. Brune has authored 41 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Urology, 14 papers in Molecular Biology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael E. Brune's work include Urinary Bladder and Prostate Research (18 papers), Hormonal and reproductive studies (9 papers) and Receptor Mechanisms and Signaling (6 papers). Michael E. Brune is often cited by papers focused on Urinary Bladder and Prostate Research (18 papers), Hormonal and reproductive studies (9 papers) and Receptor Mechanisms and Signaling (6 papers). Michael E. Brune collaborates with scholars based in United States, United Kingdom and Germany. Michael E. Brune's co-authors include Arthur A. Hancock, Steven A. Buckner, James F. Kerwin, Ivan Milicic, Michael D. Meyer, Thomas A. Fey, Robert J. Altenbach, William A. Carroll, Kennan C. Marsh and Murali Gopalakrishnan and has published in prestigious journals such as Journal of Neuroscience, Journal of Medicinal Chemistry and The Journal of Urology.

In The Last Decade

Michael E. Brune

41 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Brune United States 18 251 182 157 155 113 41 746
Steven A. Buckner United States 19 434 1.7× 335 1.8× 251 1.6× 110 0.7× 37 0.3× 57 986
Rodolfo Testa Italy 15 280 1.1× 176 1.0× 64 0.4× 124 0.8× 26 0.2× 34 617
R. Testa Italy 18 285 1.1× 251 1.4× 55 0.4× 187 1.2× 59 0.5× 49 908
James S. Polakowski United States 17 405 1.6× 35 0.2× 111 0.7× 80 0.5× 19 0.2× 39 900
A.V. Daza United States 12 253 1.0× 188 1.0× 95 0.6× 32 0.2× 28 0.2× 22 658
F Lefèvre-Borg France 18 398 1.6× 57 0.3× 74 0.5× 111 0.7× 54 0.5× 28 821
Barry Kenny United Kingdom 12 595 2.4× 236 1.3× 62 0.4× 212 1.4× 27 0.2× 19 951
Zidonia N. Carneiro United States 13 199 0.8× 74 0.4× 78 0.5× 200 1.3× 11 0.1× 19 564
Lisbeth Nilvebrant Sweden 16 362 1.4× 595 3.3× 104 0.7× 78 0.5× 19 0.2× 29 1.1k
Kazushi Minami Japan 13 263 1.0× 22 0.1× 118 0.8× 45 0.3× 24 0.2× 22 644

Countries citing papers authored by Michael E. Brune

Since Specialization
Citations

This map shows the geographic impact of Michael E. Brune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Brune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Brune more than expected).

Fields of papers citing papers by Michael E. Brune

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Brune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Brune. The network helps show where Michael E. Brune may publish in the future.

Co-authorship network of co-authors of Michael E. Brune

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Brune. A scholar is included among the top collaborators of Michael E. Brune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Brune. Michael E. Brune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohler, Eric G., Kaitlin E. Browman, Stella Markosyan, et al.. (2011). Acute Inhibition of 11β-Hydroxysteroid Dehydrogenase Type-1 Improves Memory in Rodent Models of Cognition. Journal of Neuroscience. 31(14). 5406–5413. 39 indexed citations
2.
Milicic, Ivan, Steven A. Buckner, A.V. Daza, et al.. (2006). Pharmacological characterization of urinary bladder smooth muscle contractility following partial bladder outlet obstruction in pigs. European Journal of Pharmacology. 532(1-2). 107–114. 14 indexed citations
3.
Yeh, Vince S. C., Ravi Kurukulasuriya, Steven Fung, et al.. (2006). Synthesis and biological evaluation of heterocycle containing adamantane 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(20). 5414–5419. 18 indexed citations
4.
Basso, Ana M., Natalie A. Bratcher, Marlon Cowart, et al.. (2006). Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety. European Journal of Pharmacology. 540(1-3). 115–120. 34 indexed citations
5.
Yeh, Vince S. C., Ravi Kurukulasuriya, Steven Fung, et al.. (2006). Discovery of orally active butyrolactam 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5555–5560. 13 indexed citations
6.
Hancock, Arthur A. & Michael E. Brune. (2005). Assessment of pharmacology and potential anti-obesity properties of H3receptor antagonists/inverse agonists. Expert Opinion on Investigational Drugs. 14(3). 223–241. 59 indexed citations
8.
Nakane, Masaki, Thomas A. Fey, Junli Ma, et al.. (2005). Differential effects of Vitamin D analogs on bone formation and resorption. The Journal of Steroid Biochemistry and Molecular Biology. 98(1). 72–77. 29 indexed citations
9.
Souers, Andrew J., Ju Gao, Dariusz Wódka, et al.. (2005). Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 15(11). 2752–2757. 35 indexed citations
10.
Gopalakrishnan, Murali, Steven A. Buckner, Char‐Chang Shieh, et al.. (2004). In vitro and in vivo characterization of a novel naphthylamide ATP‐sensitive K+ channel opener, A‐151892. British Journal of Pharmacology. 143(1). 81–90. 8 indexed citations
11.
Turner, Sean, William A. Carroll, Michael E. Brune, et al.. (2003). Structure–activity relationship of a novel class of naphthyl amide KATP channel openers. Bioorganic & Medicinal Chemistry Letters. 13(10). 1741–1744. 5 indexed citations
12.
Hancock, Arthur A., Steven A. Buckner, Michael E. Brune, et al.. (2002). Preclinical Pharmacology of Fiduxosin, a Novel α1-Adrenoceptor Antagonist with Uroselective Properties. Journal of Pharmacology and Experimental Therapeutics. 300(2). 478–486. 38 indexed citations
13.
14.
Witte, David G., Michael E. Brune, Ivan Milicic, et al.. (2002). Modeling of Relationships between Pharmacokinetics and Blockade of Agonist-Induced Elevation of Intraurethral Pressure and Mean Arterial Pressure in Conscious Dogs Treated with α1-Adrenoceptor Antagonists. Journal of Pharmacology and Experimental Therapeutics. 300(2). 495–504. 16 indexed citations
15.
Altenbach, Robert J., Albert Khilevich, Michael D. Meyer, et al.. (2002). N-[3-(1H-Imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1), a Novel α1-Adrenoceptor Ligand with an Enhanced in Vitro and in Vivo Profile Relative to Phenylpropanolamine and Midodrine. Journal of Medicinal Chemistry. 45(20). 4395–4397. 8 indexed citations
16.
Hancock, Arthur A., Michael E. Brune, David G. Witte, et al.. (1998). Actions of A-131701, a Novel, Selective Antagonist for Alpha-1A Compared with Alpha-1B Adrenoceptors on Intraurethral and Blood Pressure Responses in Conscious Dogs and a Pharmacodynamic Assessment of in Vivo Prostatic Selectivity. Journal of Pharmacology and Experimental Therapeutics. 285(2). 628–642. 15 indexed citations
17.
Hancock, Arthur A., et al.. (1998). Cardiovascular Activity of A-74283, a 5-Hydroxytryptamine<sub>1A</sub> Agent, in the Spontaneously Hypertensive Rat. Pharmacology. 56(1). 17–29. 5 indexed citations
18.
19.
Warner, Robert B., Michael E. Brune, Andrew Adler, et al.. (1994). Cardiovascular Effects of Orally Administered ABBOTT-81988, an Angiotensin II Antagonist, in Conscious Spontaneously Hypertensive Rats. American Journal of Hypertension. 7(11). 975–983. 2 indexed citations
20.
Winn, Martin, Biswanath De, Thomas M. Zydowsky, et al.. (1993). 2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists. Journal of Medicinal Chemistry. 36(18). 2676–2688. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026